Evidence map›Paper›PMID 32736585›Full record

ArticleParasites & vectors2020

Efficacy of a low dose fipronil bait against blacklegged tick (Ixodes scapularis) larvae feeding on white-footed mice (Peromyscus leucopus) under laboratory conditions.

David M Poché, Gregory Franckowiak, Tyler Clarke, Batchimeg Tseveenjav, Larisa Polyakova, Richard M Poché

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Why are the ticks winning, and what can we do about it?Ticks and tick-borne diseases · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Efficacy of a federally approved flea bait, orally administered to white-footed mice (International journal for parasitology. Parasites and wildlife · 2023
    Article
  8. Efficacy of Protein Baits with Fipronil to ControlAnimals : an open access journal from MDPI · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Evaluating the use of a low dose fipronil bait in reducing black-tailed prairie dog (International journal for parasitology. Parasites and wildlife · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David M PochéGenesis Laboratories, Inc., Wellington, CO, USA. davidp@genesislabs.com.
Gregory FranckowiakGenesis Laboratories, Inc., Wellington, CO, USA.
Tyler ClarkeGenesis Laboratories, Inc., Wellington, CO, USA.
Batchimeg TseveenjavGenesis Laboratories, Inc., Wellington, CO, USA.
Larisa PolyakovaGenesis Laboratories, Inc., Wellington, CO, USA.
Richard M PochéGenesis Laboratories, Inc., Wellington, CO, USA.
Genesis Laboratories · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLyme disease is the most prevalent vector-borne disease in the USA with cases continuing to increase. Current control measures have not been shown to be impactful, and therefore alternatives are needed. Treating pathogen reservoirs with low dose systemic acaricides in endemic areas may provide a useful tool for disrupting the cycle of the vector and pathogen. The purpose of this study was to determine the efficacy of a 0.005% fipronil bait, presented orally to white-footed mice, in controlling blacklegged tick larvae (larvae).

methodsSixty mice were assigned to 3 treatment groups and three untreated control groups. All individually housed mice in treatment groups were exposed to 0.005% fipronil bait for 48 hours. Larvae were manually applied to mice within feeding capsules at one of three timepoints: Day 1, Day 9 and Day 15 post-exposure. For 4-days post-tick attachment, replete larvae were collected from water moats underneath each cage and attached larvae were observed by microscopy. Plasma from 4 treated mice at Day-1, Day 13 and Day 19, and 4 control mice (n = 16) was collected to obtain fipronil plasma concentrations (CP).

resultsFipronil bait did not appear to produce neophobia in mice, as the amount of bait eaten at 24- and 48-hours exposure did not differ significantly. The 48-hour fipronil bait exposure prevented 100% of larvae from feeding to repletion at Day 1, Day 9 and Day 15 post-treatment. Within the treatment groups, all larvae observable within the capsules expired and were prevented from detaching by Day 4. In contrast, within the control groups a total of 502 replete larvae were collected from moats and 348 larvae observable within the capsules successfully detached. CP averaged 948.9, 101.2 and 79.4 ng/ml for mice euthanized at Day 1, Day 9 and Day 15, respectively. No fipronil was detected in control mice.

conclusionsWe provide early indication that low dose fipronil bait, orally presented to white-footed mice, can effectively control blacklegged tick larvae. Future research should modify the exposure duration and post-exposure tick attachment timepoints to simulate various field scenarios under which successful efficacy might be obtained. Low dose fipronil bait could provide a cost-effective, practical means of controlling blacklegged ticks and other arthropod vectors.

Indexed as

PyrazolesAnimalsArthropod VectorsDisease Models, AnimalDisease ReservoirsInsecticidesIxodesLarvaLyme DiseaseMicePeromyscusRodent DiseasesTick ControlTick InfestationsfipronilInsecticidesPyrazolesAcaricidesBlacklegged ticksBorrelia burgdorferi (sensu stricto)Fipronil baitIxodes scapularisPeromyscus leucopusSystemic insecticidesVector controlWhite-footed mice

Identifiers

PMID32736585
PMCPMC7395346
OpenAlexW3046770173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.